In a paper published in the May 5 online issue of The Oncologist, researchers at the University of California, San Diego
School of Medicine and
Moores Cancer Center detail their experience evaluating 34 patients between December 2012 and June 2013 using a molecular tumor board — a new type of advisory group comprised of multidisciplinary experts, including those in the
fields of tumor genetics, basic science and bioinformatics.